Catalyst Wire Dossier Catalyst Wire Dossier

TIME-2 Microbiome Therapy

· National Institute of Allergy and Infectious Diseases (NIAID), NIH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TIME-2 Microbiome Therapy, covering 2026-03-11 to 2026-03-11. Get the full timeline:

Most recent: Clinical Trial Update: Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2) [Phase 1]

See pricing